Report Detail

Request for Sample of this report

Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Other Indication); Drug Type (Organic Compounds, Biologics); Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies); Mode of Administration (Oral, Injectables) and Geography

RnM3946164
10 April, 2020
Global
183 Pages
The Insight Partners
Pharma & Healthcare

The global rare neurological disease treatment market is expected to reach US$13,830.96 million by 2027 from US$ 7,300.12 million in 2019. The market is estimated to grow at a CAGR of 8.5% from 2020 to 2027.

Driving factors of the rare neurological disease treatment market are growing prevalence of rare neurological diseases and favorable pipeline drugs and robust research activities for the treatment of rare neurological diseases. However, high treatment cost incurred is likely to show negative impact on market growth during the forecast period.
Rapid developments in healthcare and drug discovery are leading to the introduction of new therapeutic solutions for the treatment of rare neurological diseases. Authorities such as World Health Organization, National Institute of Neurological Disorders and Stroke, and National Institutes of Health are taking constructive steps to encourage research activities to find a remedy for rare neurological diseases. For instance, in August 2019, National Institute of Neurological Disorders and Stroke and National Center for Advancing Translational Sciences invited researchers to conduct study on rare neurological and neuromuscular diseases.
In order to cope up with rising prevalence of rare neurological diseases and geriatric population, pharmaceutical companies are actively participating in the development of drugs.
For instance, in December 2019, Healx in partnership with Boehringer Ingelheim announced a plan to discover new treatment approaches in the coming years. Additionally, they are planning to discover new therapeutic options for the treatment of fragile X syndrome and Pitt-Hopkins syndrome. Additionally, in January 2020, Ovid Therapeutics, a well-known player in rare neurological diseases treatment market, announced the enrollment of patients for pivotal Phase 3 NEPTUNE trial associated with Angelman syndrome. The results of this research study are expected in mid-2020. Such increasing awareness and developments for rare neurological diseases are likely to boost the growth of the market during the forecast period.
The global rare neurological disease treatment market is segmented into indication, drug type, distribution channel, and mode of administration. The rare neurological disease treatment market, by indication, is further segmented into narcolepsy, amyotrophic lateral sclerosis, Alzheimer’s disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchene muscular dystrophy, and other indication. Based on drug type, the rare neurological disease treatment market is further segmented into organic compounds and biologics. Based on distribution channel, the market is further segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The mode of administration segment is classified into oral, injectables.
Some of the essential primary and secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Center for Drug Evaluation and Research, Canada Foundation of Innovation, European Federation of Pharmaceuticals Industries Associations, and International Trade Administration.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Rare Neurological Disease Treatment Market– By Indication
- 1.3.2 Global Rare Neurological Disease Treatment Market– By Drug Type
- 1.3.3 Global Rare Neurological Disease Treatment Market– By Distribution Channel
- 1.3.4 Global Rare Neurological Disease Treatment Market – By Mode of Administration
- 1.3.5 Global Rare Neurological Disease Treatment Market– By Geography

2. Rare Neurological Disease Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Rare Neurological Disease Treatment– Market Landscape

4.1 Overview
4.2 Pest Analysis
- 4.2.1 North America – PEST Analysis
- 4.2.2 Europe– PEST Analysis
- 4.2.3 Asia Pacific– PEST Analysis
- 4.2.4 Middle East & Africa– PEST Analysis
- 4.2.5 South and Central America – PEST Analysis

5. Rare Neurological Disease Treatment– Key Market Dynamics

5.1 Key Market Drivers
- 5.1.1 Rising Prevalence of Rare Neurological Diseases
- 5.1.2 Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases
5.2 Key Market Restraints
- 5.2.1 High Treatment Cost for Rare Neurological Diseases
5.3 Key Market Opportunities
- 5.3.1 Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure
5.4 Future Trends
- 5.4.1 Artificial Intelligence for the Treatment of Rare Neurological Diseases
5.5 Impact Analysis

6. Rare Neurological Disease Treatment Market– Global Analysis

6.1 Global Rare Neurological Disease Treatment Market Revenue Forecast And Analysis
6.2 Global Rare Neurological Disease Treatment Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Rare Neurological Disease Treatment Market Analysis – By Indication

7.1 Overview
7.2 Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
7.3 Narcolepsy
- 7.3.1 Overview
- 7.3.2 Narcolepsy: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Amyotrophic Lateral Sclerosis
- 7.4.1 Overview
- 7.4.2 Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Alzheimer’s Disease
- 7.5.1 Overview
- 7.5.2 Alzheimer’s Disease: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Multiple Sclerosis
- 7.6.1 Overview
- 7.6.2 Multiple Sclerosis: Rare Neurological Disease Treatment Market– Revenue and Forecast to 2027 (US$ Million)
7.7 Spinal Muscular Atrophy (SMA)
- 7.7.1 Overview
- 7.7.2 Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Duchenne Muscular Dystrophy
- 7.8.1 Overview
- 7.8.2 Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
7.9 Other Indications
- 7.9.1 Overview
- 7.9.2 Other Indications: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

8. Rare Neurological Disease Treatment Market Analysis – By Drug Type

8.1 Overview
8.2 Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027, (%)
8.3 Organic Compounds
- 8.3.1 Overview
- 8.3.2 Organic Compounds: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Biologics
- 8.4.1 Overview
- 8.4.2 Biologics: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

9. Rare Neurological Disease Treatment Market Analysis – By Distribution Channel

9.1 Overview
9.2 Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027, (%)
9.3 Online Pharmacies
- 9.3.1 Overview
- 9.3.2 Online Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospital Pharmacies
- 9.4.1 Overview
- 9.4.2 Hospital Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Retail Pharmacies
- 9.5.1 Overview
- 9.5.2 Retail Pharmacies: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

10. Rare Neurological Disease Treatment Market Analysis – By Mode of Administration

10.1 Overview
10.2 Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
10.3 Oral
- 10.3.1 Overview
- 10.3.2 Oral: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Inject able
- 10.4.1 Overview
- 10.4.2 Inject able: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)

11. Rare Neurological Disease Treatment Market – Geographic Analysis

11.1 North America: Rare Neurological Disease Treatment Market
- 11.1.1 Overview
- 11.1.2 North America: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
- 11.1.3 North America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
- 11.1.4 North America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.1.5 North America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
- 11.1.6 North America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.1.7 North America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
- 11.1.8 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.8.1 US: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.8.2 US: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.1.8.3 US: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.1.8.4 US: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.1.8.5 US: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.1.9 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.9.1 Canada: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.9.2 Canada: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.1.9.3 Canada: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.1.9.4 Canada: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.1.9.5 Canada: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.1.10 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.10.1 Mexico: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.1.10.2 Mexico: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.1.10.3 Mexico: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.1.11 Mexico: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.1.11.1 Mexico: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.2 Europe: Rare Neurological Disease Treatment Market
- 11.2.1 Overview
- 11.2.2 Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
- 11.2.3 Europe: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
- 11.2.4 Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.2.5 Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
- 11.2.6 Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.2.7 Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
- 11.2.8 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.8.1 Germany: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.8.2 Germany: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.2.8.3 Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.2.8.4 Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.2.8.5 Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.2.9 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.9.1 United Kingdom: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
- 11.2.9.2United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.2.9.3 United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.2.9.4 United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.2.9.5 United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.2.10 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.10.1 France: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.10.2 France: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.2.10.3 France: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.2.10.4 France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.2.10.5 France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.2.11 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.11.1 Spain: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.11.2 Spain: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.2.11.3 Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.2.11.4 Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.2.11.5 Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.2.12 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.12.1 Italy: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.2.12.2 Italy: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.2.12.3 Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.2.12.4 Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.2.12.5 Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.3 Asia Pacific: Rare Neurological Disease Treatment Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
- 11.3.3 Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
- 11.3.4 Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.3.5 Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
- 11.3.6 Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.3.7 Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
- 11.3.8 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.8.1 China: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.8.2 China: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.3.8.3 China: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.3.8.4 China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.3.8.5 China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.3.9 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.9.1 Japan: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.9.2 Japan: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.3.9.3 Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.3.9.4 Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.3.9.5 Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.3.10 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.10.1 India: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.10.2 India: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.3.10.3 India: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.3.10.4 India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.3.10.5 India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.3.11 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.11.1 South Korea: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.11.2 South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.3.11.3 South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.3.11.4 South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.3.11.5 South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.3.12 Australia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.3.13.1 Australia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.3.13.2 Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.3.13.3 Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.3.13.4 Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.4 Middle East & Africa: Rare Neurological Disease Treatment Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
- 11.4.3 Middle East & Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
- 11.4.4 Middle East & Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.4.5 Middle East & Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
- 11.4.6 Middle East & Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.4.7 Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country – 2019 & 2027, (%)
- 11.4.8 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.4.8.1 Saudi Arabia: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.4.8.2 Saudi Arabia: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.4.8.3 Saudi Arabia: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.4.8.4 Saudi Arabia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.4.8.5 Saudi Arabia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.4.9 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.4.9.1 UAE: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.4.9.2 UAE: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.4.9.3 UAE: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.4.9.4 UAE: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.4.9.5 UAE: Rare Neurological Disease Treatment Market, by Distribution Channel , 2018–2027 (USD Million)
- 11.4.10 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (US$ Million)
  - 11.4.10.1 South Africa: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.4.10.2 South Africa: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.4.10.3 South Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.4.10.4 South Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.4.10.5 South Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
11.5 South and Central America: Rare Neurological Disease Treatment Market
- 11.5.1 Overview
- 11.5.2 South and Central America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
- 11.5.3 South and Central America: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
- 11.5.4 South and Central America: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
- 11.5.5 South and Central America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
- 11.5.6 South and Central America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.5.7 South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
- 11.5.8 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.5.8.1 Brazil: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.5.8.2 Brazil: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.5.8.3 Brazil: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.5.8.4 Brazil: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.5.8.5 Brazil: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
- 11.5.9 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.5.9.1 Argentina: Rare Neurological Disease Treatment Market – Revenue and Forecast to 2027 (USD Million)
  - 11.5.9.2 Argentina: Rare Neurological Disease Treatment Market, by Indication, 2018–2027 (USD Million)
  - 11.5.9.3 Argentina: Rare Neurological Disease Treatment Market, by Drug Type, 2018–2027 (USD Million)
  - 11.5.9.4 Argentina: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018–2027 (USD Million)
  - 11.5.9.5 Argentina: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018–2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
- 12.1 North America: Impact Assessment of COVID-19 Pandemic
- 12.2 Europe: Impact assessment of COVID-19 Pandemic
- 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
- 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Rare Neurological Disease Treatment Market –Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies In The Rare Neurological Disease Treatment Market, 2017-2020
- 13.3 Inorganic Growth Strategies
  - 13.3.1 Overview
- 13.4 Organic Growth Strategies
  - 13.4.1 Overview
14. Company Profiles
- 14.1 Allergan Plc.
  - 14.1.1 Key Facts
  - 14.1.2 Business Description
  - 14.1.3 Products and Services
  - 14.1.4 Financial Overview
  - 14.1.5 SWOT Analysis
  - 14.1.6 Key Developments
- 14.2 Bayer AG
  - 14.2.1 Key Facts
  - 14.2.2 Business Description
  - 14.2.3 Products and Services
  - 14.2.4 Financial Overview
  - 14.2.5 SWOT Analysis
  - 14.2.6 Key Developments
- 14.3 GlaxoSmithKline plc.
  - 14.3.1 Key Facts
  - 14.3.2 Business Description
  - 14.3.3 Products and Services
  - 14.3.4 Financial Overview
  - 14.3.5 SWOT Analysis
  - 14.3.6 Key Developments
- 14.4 Johnson & Johnson Services, Inc.
  - 14.4.1 Key Facts
  - 14.4.2 Business Description
  - 14.4.3 Products and Services
  - 14.4.4 Financial Overview
  - 14.4.5 SWOT Analysis
  - 14.4.6 Key Developments
- 14.5 Merck & Co., Inc.
  - 14.5.1 Key Facts
  - 14.5.2 Business Description
  - 14.5.3 Products and Services
  - 14.5.4 Financial Overview
  - 14.5.5 SWOT Analysis
  - 14.5.6 Key Developments
- 14.6 Novartis AG
  - 14.6.1 Key Facts
  - 14.6.2 Business Description
  - 14.6.3 Products and Services
  - 14.6.4 Financial Overview
  - 14.6.5 SWOT Analysis
  - 14.6.6 Key Developments
- 14.7 Pfizer Inc.
  - 14.7.1 Key Facts
  - 14.7.2 Business Description
  - 14.7.3 Products and Services
  - 14.7.4 Financial Overview
  - 14.7.5 SWOT Analysis
  - 14.7.6 Key Developments
- 14.8 Sanofi
  - 14.8.1 Key Facts
  - 14.8.2 Business Description
  - 14.8.3 Products and Services
  - 14.8.4 Financial Overview
  - 14.8.5 SWOT Analysis
  - 14.8.6 Key Developments
- 14.9 Teva Pharmaceutical Industries Ltd
  - 14.9.1 Key Facts
  - 14.9.2 Business Description
  - 14.9.3 Products and Services
  - 14.9.4 Financial Overview
  - 14.9.5 SWOT Analysis
  - 14.9.6 Key Developments
- 14.10 Takeda Pharmaceutical Company Limited
  - 14.10.1 Key Facts
  - 14.10.2 Business Description
  - 14.10.3 Products and Services
  - 14.10.4 Financial Overview
  - 14.10.5 SWOT Analysis
  - 14.10.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms

Proanthocyanidins Market Report

Biopharmaceutical Contract Manufacturing Market Report

Summary:
Get latest Market Research Reports on Rare Neurological Disease Treatment . Industry analysis & Market Report on Rare Neurological Disease Treatment is a syndicated market report, published as Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication (Narcolepsy, Amyotrophic Lateral Sclerosis, Alzheimer’s Disease, Multiple Sclerosis, Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy, Other Indication); Drug Type (Organic Compounds, Biologics); Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies); Mode of Administration (Oral, Injectables) and Geography . It is complete Research Study and Industry Analysis of Rare Neurological Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 10 April, 2020

1-User License	$4,550.00
Site License	$6,550.00
Enterprise License	$8,550.00

1-User License	3,630.90
Site License	5,226.90
Enterprise License	6,822.90

1-User License	4,249.70
Site License	6,117.70
Enterprise License	7,985.70

1-User License	711,028.50
Site License	1,023,568.50
Enterprise License	1,336,108.50

1-User License	379,879.50
Site License	546,859.50
Enterprise License	713,839.50

Report Detail

Request for Sample of this report

Request for Sample of this report

Table Of Content

TABLE OF CONTENTS

1. Introduction

2. Rare Neurological Disease Treatment Market – Key Takeaways

3. Research Methodology

4. Rare Neurological Disease Treatment– Market Landscape

5. Rare Neurological Disease Treatment– Key Market Dynamics

6. Rare Neurological Disease Treatment Market– Global Analysis

7. Rare Neurological Disease Treatment Market Analysis – By Indication

8. Rare Neurological Disease Treatment Market Analysis – By Drug Type

9. Rare Neurological Disease Treatment Market Analysis – By Distribution Channel

10. Rare Neurological Disease Treatment Market Analysis – By Mode of Administration

11. Rare Neurological Disease Treatment Market – Geographic Analysis

12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

13. Rare Neurological Disease Treatment Market –Industry Landscape

14. Company Profiles

15. Appendix

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

Related Reports

Reason to Buy

Trusted By Leaders

Shop With Confidence

Customer Centric

Personalized Solutions

Secure Checkout

Request for Sample of this report

Reports and Markets

Contact Us

Support

Newsletter